Medtronic (NYSE:MDT) received CE Mark approval in Europe for its Affera Sphere-360 pulsed field ablation catheter for cardiac ablation procedures. The company has started pivotal U.S. clinical trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results